#Japan #Tokyo #Kokoromil #eclat #ECG Patch

Introduction

In a remarkable advancement for healthcare technology, Kokoromil, a medical device company based in Shinjuku, Tokyo, has successfully introduced Japan's first fully disposable patch-type Holter electrocardiogram (ECG) device, named eclat. Within just a year of its release, eclat has gained significant traction in medical institutions nationwide, earning prestigious recognition from the Furukawa Medical Welfare Equipment Promotion Foundation.

Distinction and Recognition

The eclat ECG device was honored as part of the 13th Award and Research Grant initiative hosted by the foundation, highlighting its innovative contributions to reducing the workload for healthcare professionals while simultaneously minimizing patient discomfort. This recognition is particularly pertinent in Japan, where there's an increasing need to address practitioner shortages and reforms in medical working conditions.

Three Key Points of Evaluation

The selection committee emphasized three main points regarding the success of the eclat device:

1. Rapid Adoption in Healthcare Facilities

In less than a year from its launch in November 2024, the eclat device has been implemented in various healthcare facilities, including numerous university hospitals across Japan. This quick adoption reflects a strong underlying demand for solutions tailored to the pressing challenges faced in healthcare settings. The eclat's introduction is seen as a timely resolution to a profound need within the medical community.

2. Transformation of Patient Experience

Traditional Holter ECG tests involve cumbersome processes for patients, including multiple electrode connections that can be uncomfortable, restrictions on bathing, and return visits for equipment submission. eclat, being the first patch-type Holter ECG in Japan, is designed for complete disposability. It eliminates wires and allows for uninterrupted daily activities for seven days. Patients can now bathe and sleep without disruption. The return process is also simplified as the device is shipped back directly, significantly reducing the workload for patients, especially those coming from distant locations.

3. Streamlining Operations for Medical Staff

The remarkable feature of eclat is its entirely disposable nature, which eradicates the requirement for device retrieval, cleaning, and disinfection after tests. This not only alleviates the burden on medical professionals but also eliminates the need for device recharging for two years following production. Consequently, healthcare providers can perform immediate tests as needed without the complication of battery maintenance or management. Furthermore, it includes analysis by clinical laboratory technicians and cardiologists, thereby relieving healthcare staff from additional analytic responsibilities.

Conclusion

This innovative approach is a direct response to Japan's pressing need for reform in healthcare personnel work practices. By focusing on reducing workload, Kokoromil aims to allow medical professionals to dedicate more time to patient dialogue and accurate diagnostics.

Product Overview: eclat

The eclat device exemplifies cutting-edge technology in electrocardiogram testing.

Main Features:

1. Fully Disposable Design: No device retrieval, cleaning, or disinfection needed—enhancing both efficiency and safety in healthcare environments.
2. Patient-Friendly Usage: Enables a seamless seven-day continuous monitoring process without disrupting daily life activities.
3. Maintenance-Free Operation: Does not require recharging for two years, facilitating immediate availability for patient testing.

For more information about Kokoromil and its services, please visit the official website here.

Acknowledgment from Kokoromil's President

President Hiroshi Hayashi expressed gratitude for this esteemed award, stating that the swift acceptance of eclat reflects a collective demand within the medical sector for reduced burdens on both professionals and patients. This accolade propels us forward in our mission to develop innovative devices that bolster Japan's healthcare infrastructure, addressing key societal challenges effectively.

Company Information

Kokoromil Co., Ltd.

• - President: Hiroshi Hayashi
• - Location: 2F Kanou Building, 6-2-16 Nishi-Shinjuku, Shinjuku-ku, Tokyo, 160-0023
• - Established: November 2021
• - Operations: Healthcare and clinical research services

For inquiries: [email protected]